Back
IVI - International Vaccine Institute Joins CEPI's Global Vaccine Testing Network
webThis resource covers a public health partnership between IVI and CEPI focused on pandemic vaccine preparedness; it is largely tangential to AI safety topics but may be marginally relevant to biosecurity and global coordination discussions.
Metadata
Importance: 12/100press releasenews
Summary
The International Vaccine Institute (IVI) has joined CEPI's Global Vaccine Testing Network (GVTN), a collaboration aimed at strengthening pandemic preparedness by expanding vaccine trial capacity across diverse geographic regions. This partnership supports rapid response to future epidemic and pandemic threats by enabling coordinated clinical testing infrastructure.
Key Points
- •IVI joins CEPI's Global Vaccine Testing Network (GVTN) to bolster international pandemic preparedness efforts.
- •The partnership expands clinical trial capacity for vaccines in regions critical for epidemic response.
- •CEPI's GVTN aims to coordinate and accelerate vaccine testing during health emergencies.
- •IVI's expertise in low- and middle-income country vaccine research strengthens the network's global reach.
Cited by 1 page
| Page | Type | Quality |
|---|---|---|
| Coalition for Epidemic Preparedness Innovations | Organization | 53.0 |
Cached Content Preview
HTTP 200Fetched Apr 7, 202681 KB
International Vaccine Institute joins CEPI’s global vaccine testing network to strengthen pandemic preparedness - IVI
International Vaccine Institute joins CEPI’s global vaccine testing network to strengthen pandemic preparedness
Home
Main News
International Vaccine Institute joins CEPI’s global vaccine testing network to strengthen pandemic preparedness
August 6, 2025 , SEOUL, Republic of Korea — The International Vaccine Institute (IVI) has joined the world’s largest network of laboratories working to accelerate the development of vaccines targeting epidemic and pandemic threats.
The Centralised Laboratory Network, led by the Coalition for Epidemic Preparedness Innovations (CEPI), establishes a common framework of tools and protocols to standardize how new vaccine candidates are evaluated across member laboratories. The laboratories at IVI’s headquarters in Seoul and the Korea Disease Control and Prevention Agency (KDCA) are the first in Korea to join the network, which now includes 20 labs across Africa, the Americas, Asia, Australasia, and Europe.
By reducing variability in how data is generated across laboratories, the network helps address the challenge of comparing vaccine candidates tested using different methods. This standardization can support researchers and regulators in Korea and beyond to more quickly identify the most promising vaccine candidates.
“The inclusion of IVI and KDCA in CEPI’s Centralised Laboratory Network will facilitate harmonized and expedited evaluation of vaccine candidates during epidemics and pandemics,” says Dr. Manki Song, Deputy Director General of Science at IVI. “By joining this global network, IVI and KDCA can further increase their contributions to pandemic preparedness and global health security by enhancing our shared capabilities in clinical sample analysis and vaccine development.”
“When multiple vaccine candidates are undergoing testing, differences in how data is collected becomes an issue. As well as potential variations in markers of immunity, there can be distinctions in how and where samples are collected, transported and stored” explains Dr. Kent Kester, Executive Director of Vaccine R&D at CEPI. “This impacts the quality and usefulness of the data produced. IVI and KDCA’s new membership to our Centralised Laboratory Network will lessen these problems, to more reliably and quickly evaluate potentially life-saving vaccines under development.”
“By joining CEPI’s Centralised Laboratory Network together with IVI, KDCA expects to strengthen global partnerships in vaccine evaluation, enhancing preparedness for emerging infectious diseases and potential pandemic preparedness,” says Dr. Seungkwan Lim, Commissioner of KDCA. “To strengthen global health security, w
... (truncated, 81 KB total)Resource ID:
342eaf335f825b23 | Stable ID: sid_BbHWKMBoz2